US Broker Ratings

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with a 5.74% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands at the forefront of the biotechnology industry with a strategic focus on developing and commercializing pharmaceutical products across the globe. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 9.72% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, stands at an intriguing juncture for investors eyeing the medical instruments and supplies industry. With a market capitalization of..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Investment Potential in a Stagnant Market

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, is a company that commands attention, especially for those keeping an eye on the healthcare industry. With a market..

Natera, Inc. (NTRA) Investor Outlook: Strong Buy Ratings and Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured significant investor interest, thanks to a combination of robust revenue growth and..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 23.41% Potential Upside with Robust Dividend Yield

As an investor in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing opportunity with its extensive portfolio in medical devices. Headquartered in Amsterdam, Netherlands, Philips operates globally,..

Masimo Corporation (MASI) Stock Analysis: A Steady Performer with a Strong ROE and Consistent Growth

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specializes in medical devices with a focus on patient monitoring technologies. Headquartered in Irvine, California, Masimo has carved out..

Viatris Inc. (VTRS) Stock Analysis: Navigating Growth in the Healthcare Sector with a 3% Upside Potential

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is making waves among investors with its strategic positioning in the drug manufacturing industry, particularly in specialty and generic..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a 15.68% Potential Upside for Investors

For investors with an eye on the biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling opportunity, boasting a potential upside of 15.68% according to recent analyst ratings. With..

Repligen Corporation (RGEN) Investor Outlook: A 20.92% Potential Upside Beckons Amid Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN), a significant player in the healthcare sector specializing in medical instruments and supplies, offers a compelling prospect for investors drawn by its potential upside and solid..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 25% Upside Potential for Investors

ResMed Inc. (NYSE: RMD), a key player in the healthcare sector, continues to capture investor attention with its robust portfolio of medical instruments and cloud-based software solutions targeting respiratory disorders...

Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector might find Alcon Inc. (NYSE: ALC) an intriguing candidate, particularly with its promising 24.66% potential upside based on analysts’ average target price. As..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 108.75% Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical company with a focus on developing groundbreaking therapies, is making waves in the biotechnology sector. With a market capitalization of $10.72 billion, Summit..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Booming Biotech with a 42.2% Revenue Growth

Investors looking for a compelling opportunity in the biotechnology sector might find Halozyme Therapeutics, Inc. (NASDAQ: HALO) an intriguing prospect. With a market capitalization of $9.23 billion, this San Diego-based..

Humana Inc. (HUM) Stock Analysis: Evaluating the Healthcare Giant’s Market Position and Performance Metrics

For investors keen on the healthcare sector, Humana Inc. (NYSE: HUM) presents an intriguing opportunity, given its robust market position and impressive revenue growth figures. As a leading player in..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 27.81% Potential Upside in Health Information Services

Tempus AI, Inc. (NASDAQ: TEM) is a healthcare technology company making waves in the health information services industry. Headquartered in Chicago, Illinois, Tempus AI specializes in cutting-edge genomic testing and..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Why Analysts Are Bullish on This $39.58 Billion Biotech Innovator

Revolution Medicines, Inc. (NASDAQ: RVMD), a leader in the biotech industry with a market capitalization of $39.58 billion, is capturing investor attention with its focus on precision oncology therapies. Headquartered..

ICON plc (ICLR) Stock Analysis: Assessing Growth Potential and Analyst Ratings in the Healthcare Sector

ICON plc (NASDAQ: ICLR), headquartered in Dublin, Ireland, stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.11..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring the 23.86% Potential Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic drugs. With a market capitalization of..

Penumbra, Inc. (PEN) Stock Analysis: Evaluating a 13.89% Potential Upside in the Medical Devices Sector

Penumbra, Inc. (NASDAQ: PEN), an influential player in the healthcare sector’s medical devices industry, offers a compelling investment opportunity with a potential upside of 13.89%. Established in 2004 and headquartered..

Grifols, S.A. (GRFS) Stock Analysis: Unlocking Potential with a 49.45% Upside

Investors seeking opportunities in the healthcare sector might want to turn their attention to Grifols, S.A. (NASDAQ: GRFS), a Spanish giant in the drug manufacturing industry. Despite the recent turbulence..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds